Mr. Kirske

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when X4 Pharmaceuticals, Inc publishes a filing, an earnings call transcript or a press release.

Get XFOR alerts

About Mr. Kirske

Mr. Kirske is recorded as CFO at X4 Pharmaceuticals, Inc (XFOR) since August 12, 2025. X4 Pharmaceuticals, Inc reported in an 8-K filed August 12, 2025 that Mr. Kirske was appointed Chief Financial Officer, effective August 12, 2025. X4 Pharmaceuticals, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at X4 Pharmaceuticals, Inc includes Adam Raymond Craig, M.D., Ph.D. (CEO, Chairman and Board Member), Michael Gray (CEO), Paula Ragan (CEO) and 7 others.

“On August 12, 2025, the Company issued a press release announcing the pricing of the Private Placement, the appointments of Dr. Craig as the Executive Chairman and a director, Mr. Kirske as Chief Financial Officer and Mr. Volpone as President.”

X4 Pharmaceuticals, Inc Form 8-K, filed August 12, 2025 · Read the filing

Affiliation history

X4 Pharmaceuticals, Inc (XFOR)
CFO

SEC 8-K

Current
2025-08-12–present

Company network

X4 Pharmaceuticals, Inc

XFOR

Current role

Biotechnology · Healthcare

CFO

2025-08-12–present

Leadership on record at X4 Pharmaceuticals, Inc

Adam Raymond Craig, M.D., Ph.D. CEO, Chairman, Board Member
Michael Gray CEO
Paula Ragan CEO
Adam Craig Chairman
Adam R. Craig Chairman
Dr. Craig Chairman, Board Member
David H. Kirske CFO
David Kirske CFO
John Volpone COO
Mary DiBiase, Ph.D. COO

Recent activity

Executive change Appointed: Chief Financial Officer X4 Pharmaceuticals, Inc (XFOR)
2025-08-12